Wyeth Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wyeth Pakistan Limited with three other
pharmaceutical manufacturers in Asia:
Biostar Pharmaceuticals Incorporation
sales of 170.59 million Chinese Renmimbi [US$25.32 million]
Syncom Formulations (India) Limited
(1.73 billion Indian Rupees [US$26.01 million]
Lyka Labs Limited
based in India
(1.66 billion Indian Rupees [US$24.94 million]
During the year ended November of 2015, sales at
Wyeth Pakistan Limited were 2.67 billion Pakistan Rupees (US$25.54 million).
decrease of 12.4%
versus 2014, when the company's sales were 3.05 billion Pakistan Rupees.